The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence

被引:0
|
作者
Salimovic-Besic, Irma [1 ]
Dedeic-Ljubovic, Amela [1 ]
Zahirovic, Edina [1 ]
Hasanovic, Medina [1 ]
Sehic, Merima [1 ]
Vukovikj, Maja [2 ]
Boshevska, Golubinka [3 ]
Vegar-Zubovic, Sandra [1 ]
Mehmedika-Suljic, Enra [1 ]
Izetbegovic, Sebija [1 ]
机构
[1] Univ Sarajevo, Clin Ctr, Bolnicka 25, Sarajevo 71000, Bosnia & Herceg
[2] Inst Publ Hlth Republ North Macedonia, 50-Ta Div 6, Skopje 1000, North Macedonia
[3] Univ Goce Delchev, Fac Med Sci, Krste Misirkov 10-A POB 201, Shtip 2000, North Macedonia
关键词
SARS-CoV-2; N501Y; Delta variant; Omicron variant; COVID-19; Pandemic; Spike protein; RECEPTOR-BINDING DOMAIN; ACCURATE; ACE2;
D O I
10.1016/j.heliyon.2022.e12650
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Circulation of the Omicron variant with the reemergence of the N501Y mutation along with many others in the spike protein has once again stirred the academic community. Interestingly, tracing the genetic diversity of SARS-CoV-2 shed light on a less frequent N501Y + Delta variant which has been in the global circulation for some time before the Omicron appearance. This paper aims to present the molecular characteristics of the SARS-CoV-2 Spike_N501Y + Delta variant detected in Bosnia and Herzegovina. The study was conducted during November and December 2021. All patients were tested using real-time RT-PCR for detection of SARS-CoV-2. A representative number of SARS-CoV-2 positive samples was pre-screened using VirSNiP SARS-CoV-2 Spike N501Y kit. The characterization of the viruses was carried out with Illumina RNA Prep with enrichment and the Respiratory Virus Oligo Panel kit. Among the analyzed sequences, we found two isolates of the Delta variant that differ from their most related clade- GK AY.4.3 in additional mutations N501Y and L54F. In this study, we described the presence of a rare form of Delta variant with Spike_N501Y mutation in the shadow of the Omicron emergence. Despite the set of mutations in the Spike protein, this form of Delta variant does not indicate the large-scale consequences for the general population. Further functional studies of this form could provide more information about its antigenicity and infectivity.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic
    Rostami, Neda
    Choupani, Edris
    Hernandez, Yaeren
    Arab, Seyed S.
    Jazayeri, Seyed M.
    Gomari, Mohammad M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (02) : 417 - 430
  • [32] Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2
    Li, Gun
    Zhang, Liang
    Xue, Pei
    INFECTION GENETICS AND EVOLUTION, 2022, 97
  • [33] Breakthrough infections with SARS-CoV-2 B.1.617.2 variant B.1.617.2 and humoral reponse in vaccinated maintenance hemodialysis patients
    Wand, O.
    Nacasch, N.
    Benchetrit, S.
    Cohen-Hagai, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
    Colson, Philippe
    Delerce, Jeremy
    Burel, Emilie
    Dahan, Jordan
    Jouffret, Agnes
    Fenollar, Florence
    Yahi, Nouara
    Fantini, Jacques
    La Scola, Bernard
    Raoult, Didier
    ARCHIVES OF VIROLOGY, 2022, 167 (04) : 1185 - 1190
  • [35] Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus
    Tuncel, Gulten
    Ergoren, Mahmut Cerkez
    Baddal, Buket
    Tulay, Pinar
    Ozverel, Cenk Serhan
    Guler, Emrah
    Suer, Huseyin Kaya
    Sayan, Murat
    Sanlidag, Tamer
    FUTURE VIROLOGY, 2022, 17 (08) : 523 - 528
  • [36] In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
    Cubuk, Hasan
    Ozbil, Mehmet
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 116
  • [37] Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
    Vercueil, Colin
    Eberst, Lauriane
    Humbrecht, Catherine
    Fornecker, Luc-Matthieu
    HEMASPHERE, 2021, 5 (12): : E655
  • [38] Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
    Philippe Colson
    Jérémy Delerce
    Emilie Burel
    Jordan Dahan
    Agnès Jouffret
    Florence Fenollar
    Nouara Yahi
    Jacques Fantini
    Bernard La Scola
    Didier Raoult
    Archives of Virology, 2022, 167 : 1185 - 1190
  • [39] Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats
    Hoyte, Ashley
    Webster, Mark
    Ameiss, Keith
    Conlee, Douglas A.
    Hainer, Nicole
    Hutchinson, Kendra
    Burakova, Yulia
    Dominowski, Paul J.
    Baima, Eric T.
    King, Vickie L.
    Rosey, Everett L.
    Hardham, John M.
    Millership, Jason
    Kumar, Mahesh
    VETERINARY MICROBIOLOGY, 2022, 268
  • [40] Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
    Connor, Bradley A.
    Couto-Rodriguez, Mara
    Barrows, Joseph E.
    Gardner, Morgan
    Rogova, Marina
    O'Hara, Niamh B.
    Nagy-Szakal, Dorottya
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 110 : 232 - 234